Neoplasm Staging

"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Descriptor ID	D009367
MeSH Number(s)	E01.789.625
Concept/Terms	Neoplasm Staging Neoplasm Staging Staging, Neoplasm Tumor Staging Staging, Tumor Cancer Staging Staging, Cancer TNM Staging TNM Staging Staging, TNM TNM Staging System Staging System, TNM Staging Systems, TNM System, TNM Staging Systems, TNM Staging TNM Staging Systems TNM Classification Classification, TNM Classifications, TNM TNM Classifications

Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]
Neoplasm Staging [E01.789.625]

Below are MeSH descriptors whose meaning is related to "Neoplasm Staging".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.

Bar chart showing 301 publications over 27 distinct years, with a maximum of 32 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1998	0	1	1
2001	0	1	1
2002	0	5	5
2003	0	6	6
2004	1	7	8
2005	0	14	14
2006	0	12	12
2007	0	9	9
2008	0	12	12
2009	0	10	10
2010	0	10	10
2011	0	10	10
2012	0	13	13
2013	0	14	14
2014	0	15	15
2015	1	21	22
2016	1	31	32
2017	0	24	24
2018	1	18	19
2019	2	7	9
2020	0	12	12
2021	0	13	13
2022	0	4	4
2023	0	3	3
2024	2	7	9
2025	0	13	13

Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.

Matsuo K, Enserro DM, Wright JD, Roman LD, Powell MA, Miller DS, Nagel CI, Thaker PH, Mannel RS, Stuckey AR, Guntupalli SR, Sukumvanich P, Geller MA, Vargas R, Konecny GE, Warshal DP, Tewari KS, Spirtos NM, Pothuri B, Creasman WT, Mutch DG. Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2025 Oct; 201:184-194.

View in: PubMed
Suk R, Lin YY, Dilley S, Chandler R, Xiao R, Shao H, Wells J. Survival by Treatment Recommendation and Receipt Among Older Patients With Early-Stage Cervical Cancer. JAMA Netw Open. 2025 Sep 02; 8(9):e2532206.

View in: PubMed
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA. Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma. Clin Genitourin Cancer. 2025 Dec; 23(6):102422.

View in: PubMed
Sherr HR, Soliman AS, Bertrand KA, Hirko KA. Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021. Cancer Causes Control. 2025 Nov; 36(11):1589-1597.

View in: PubMed
Bertini A, Tylecki A, Stephens A, Finocchiaro A, Vigan? S, Cusmano N, Dinesh A, Guivatchian E, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. Socioeconomic Disparities in Prostate Cancer Presentation: The Impact of ADI on Prostate Cancer Stage at Diagnosis. Clin Genitourin Cancer. 2025 Dec; 23(6):102418.

View in: PubMed
Patel R, Fukui J, Klein P, Moshier E, Kocyigit H, Fiedler L, Bucwinska W, Xing XY, Shapiro C, Goel A, Fasano J, Shao T, Bhardwaj A, Kim E, Vaccaro R, Lee K, Wilck E, Tiersten A. Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer. Breast Cancer Res Treat. 2025 Nov; 214(2):159-170.

View in: PubMed
Akinyemi O, Ogunyankin F, Fasokun M, Abodunrin F, Eze O, Ndebele-Ngwenya P, Geter K, Hughes K, Lawson S. Medicaid expansion and overall mortality among women with cervical cancer. Int J Gynaecol Obstet. 2026 Jan; 172(1):343-350.

View in: PubMed
Finocchiaro A, Tylecki A, Vigan? S, Bertini A, Ficarra V, Di Trapani E, Salonia A, Briganti A, Montorsi F, Lughezzani G, Buffi N, Sood A, Rogers C, Abdollah F. Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis. JNCI Cancer Spectr. 2025 Jul 01; 9(4).

View in: PubMed
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA. Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma. Urol Oncol. 2025 Oct; 43(10):597.e5-597.e14.

View in: PubMed
Wolf DM, Yau C, Campbell M, Glas A, Barcaru A, Mittempergher L, Kuilman M, Brown-Swigart L, Hirst G, Basu A, Magbanua M, Sayaman R, Huppert L, Delson A, Symmans WF, Borowsky A, Pohlmann P, Rugo H, Clark A, Yee D, DeMichele A, Perlmutter J, Petricoin EF, Chien J, Stringer-Reasor E, Shatsky R, Liu M, Han H, Soliman H, Isaacs C, Nanda R, Hylton N, Pusztai L, Esserman L, van 't Veer L. Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial. JCO Precis Oncol. 2025 Jun; 9:e2400776.

View in: PubMed

People

Explore

Similar Concepts

Top Journals